ResearcherNingbo UniversityActive in the last 2 years
Yeting Lu
Matched on ORCID iD 0000-0001-7890-6775; OpenAlex author ID A5043618634. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 9
2022: 2 papers · 2023: none · 2024: none · 2025: 3 papers
Papers 5
- Deciphering the senescence-based tumoral heterogeneity and characteristics in pancreatic cancer: Results from parallel bulk and single-cell transcriptome data. Co-author DOI 10.1002/iub.70001↗
- The Role and Mechanism of KIAA1429-Mediated m6A Modification in Pancreatic Adenocarcinoma. First author DOI 10.1002/mc.70015↗
- Hypoxia-Challenged Pancreatic Adenocarcinoma Cell-Derived Exosomal circR3HCC1L Drives Tumor Growth Via Upregulating PKM2 Through Sequestering miR-873-5p. Co-author DOI 10.1007/s12033-024-01091-z↗
- LncRNA LINC01857 drives pancreatic adenocarcinoma progression via modulating miR-19a-3p/SMOC2. Co-author DOI 10.1016/j.clinsp.2022.100047↗
- CircLMTK2 Silencing Attenuates Gemcitabine Resistance in Pancreatic Cancer by Sponging miR-485-5p and to Target PAK1. Co-author DOI 10.1155/2022/1911592↗
Closest collaborators
The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Xinhua Zhou · 3 shared papers, 2022–2025 · strength 0.63
- Paper Deciphering the senescence-based tumoral heterogeneity and characteristics in pancreatic cancer: Results from parallel … DOI 10.1002/iub.70001↗
- Paper Hypoxia-Challenged Pancreatic Adenocarcinoma Cell-Derived Exosomal circR3HCC1L Drives Tumor Growth Via Upregulating PKM… DOI 10.1007/s12033-024-01091-z↗
- Paper LncRNA LINC01857 drives pancreatic adenocarcinoma progression via modulating miR-19a-3p/SMOC2. DOI 10.1016/j.clinsp.2022.100047↗
- Shuo Han · 3 shared papers, 2022–2025 · strength 0.58
- Paper Deciphering the senescence-based tumoral heterogeneity and characteristics in pancreatic cancer: Results from parallel … DOI 10.1002/iub.70001↗
- Paper LncRNA LINC01857 drives pancreatic adenocarcinoma progression via modulating miR-19a-3p/SMOC2. DOI 10.1016/j.clinsp.2022.100047↗
- Paper CircLMTK2 Silencing Attenuates Gemcitabine Resistance in Pancreatic Cancer by Sponging miR-485-5p and to Target PAK1. DOI 10.1155/2022/1911592↗
- Xiang Wu · 2 shared papers, 2025 · strength 0.47
- Paper Deciphering the senescence-based tumoral heterogeneity and characteristics in pancreatic cancer: Results from parallel … DOI 10.1002/iub.70001↗
- Paper Hypoxia-Challenged Pancreatic Adenocarcinoma Cell-Derived Exosomal circR3HCC1L Drives Tumor Growth Via Upregulating PKM… DOI 10.1007/s12033-024-01091-z↗
- Dongjian Ying · 2 shared papers, 2022–2025 · strength 0.39
- Jing Hu · 1 shared paper, 2025 · strength 0.33
- Pengbo Li · 1 shared paper, 2025 · strength 0.33
- Luoluo Wang · 1 shared paper, 2025 · strength 0.22
- Xinhua Zhou · 1 shared paper, 2022 · strength 0.16
- Yuan Tian · 1 shared paper, 2022 · strength 0.16
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.